Bank of America analyst dubs Moderna stock price as ridiculous

Natural News ) An analyst for Bank of America (BofA) has dubbed Moderna’s current stock price as “ridiculous.” BofA Securities Analyst Geoff Meacham said the Massachusetts-based biotechnology firm’s valuation is “unjustifiable on a fundamental basis.” Meacham’s Aug. 10 analysis ultimately suggested that Moderna’s stock should be 75 percent lower than its current price.

Read the source article at naturalnews.com
2021-08-19 11:43:11